153 related articles for article (PubMed ID: 35016848)
1. ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S.
Yuan L; Zhao J; Zhao S; Dong T; Dong R; Liu D; Ma E; Li Y
Chem Biol Interact; 2022 Feb; 353():109811. PubMed ID: 35016848
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells.
Huang H; Zhang Y; Xu X; Liu Y; Zhao J; Ma L; Lei J; Ge W; Li N; Ma E; Li Y; Yuan L
Bioorg Med Chem Lett; 2023 Jan; 80():129087. PubMed ID: 36427655
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel cathepsin inhibitors with potent anti-metastatic effects in breast cancer cells.
Yuan L; Sheng L; He W; Zou C; Hu B; Liu J; Ge W; Liu Y; Wang J; Ma E
Bioorg Chem; 2018 Dec; 81():672-680. PubMed ID: 30253340
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel cathepsin inhibitor with dual autophagy-inducing and metastasis-inhibiting effects on breast cancer cells.
Yuan L; Liu J; He W; Bao Y; Sheng L; Zou C; Hu B; Ge W; Liu Y; Wang J; Lin B; Li Y; Ma E
Bioorg Chem; 2019 Mar; 84():239-253. PubMed ID: 30503850
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel and selective cathepsin L inhibitor with anti-metastatic ability in vitro and in vivo against breast cancer cells.
Li Y; Ai X; Zou C; Liu Y; Ma L; Men J; Liu D; Sheng L; Ruan X; Liu H; Li W; Ma E; Yuan L
Bioorg Chem; 2021 Oct; 115():105256. PubMed ID: 34426153
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
[TBL] [Abstract][Full Text] [Related]
7. The effect of catalase on migration and invasion of lung cancer cells by regulating the activities of cathepsin S, L, and K.
Tsai JY; Lee MJ; Dah-Tsyr Chang M; Huang H
Exp Cell Res; 2014 Apr; 323(1):28-40. PubMed ID: 24583396
[TBL] [Abstract][Full Text] [Related]
8. Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells.
Tsai JY; Lee MJ; Chang MD; Wang HC; Lin CC; Huang H
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):538-46. PubMed ID: 24083411
[TBL] [Abstract][Full Text] [Related]
9. Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model.
Elie BT; Gocheva V; Shree T; Dalrymple SA; Holsinger LJ; Joyce JA
Biochimie; 2010 Nov; 92(11):1618-24. PubMed ID: 20447439
[TBL] [Abstract][Full Text] [Related]
10. SAR studies of some acetophenone phenylhydrazone based pyrazole derivatives as anticathepsin agents.
Raghav N; Singh M
Bioorg Chem; 2017 Dec; 75():38-49. PubMed ID: 28915464
[TBL] [Abstract][Full Text] [Related]
11. Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells.
Wilder CL; Walton C; Watson V; Stewart FAA; Johnson J; Peyton SR; Payne CK; Odero-Marah V; Platt MO
Int J Biochem Cell Biol; 2016 Oct; 79():199-208. PubMed ID: 27592448
[TBL] [Abstract][Full Text] [Related]
12. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C
Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702
[TBL] [Abstract][Full Text] [Related]
13. Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice.
Xiao Z; Li L; Li Y; Zhou W; Cheng J; Liu F; Zheng P; Zhang Y; Che Y
Cell Death Dis; 2014 May; 5(5):e1241. PubMed ID: 24853419
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose.
Jung M; Lee J; Seo HY; Lim JS; Kim EK
PLoS One; 2015; 10(1):e0116972. PubMed ID: 25625842
[TBL] [Abstract][Full Text] [Related]
15. 2,5-Diaryloxadiazoles and their precursors as novel inhibitors of cathepsins B, H and L.
Garg S; Raghav N
Bioorg Chem; 2016 Aug; 67():64-74. PubMed ID: 27285276
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism.
Zheng X; Chu F; Chou PM; Gallati C; Dier U; Mirkin BL; Mousa SA; Rebbaa A
Am J Physiol Cell Physiol; 2009 Jan; 296(1):C65-74. PubMed ID: 18971393
[TBL] [Abstract][Full Text] [Related]
17. Quinazoline derivatives as cathepsins B, H and L inhibitors and cell proliferating agents.
Raghav N; Jangra S; Kumar A; Bhattacharyya S
Int J Biol Macromol; 2017 Jan; 94(Pt A):719-727. PubMed ID: 27780761
[TBL] [Abstract][Full Text] [Related]
18. Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors.
Vázquez R; Astorgues-Xerri L; Bekradda M; Gormley J; Buick R; Kerr P; Cvitkovic E; Raymond E; D'Incalci M; Frapolli R; Riveiro ME
Biochimie; 2015 Jan; 108():101-7. PubMed ID: 25446656
[TBL] [Abstract][Full Text] [Related]
19. Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituent.
Kerns JK; Nie H; Bondinell W; Widdowson KL; Yamashita DS; Rahman A; Podolin PL; Carpenter DC; Jin Q; Riflade B; Dong X; Nevins N; Keller PM; Mitchell L; Tomaszek T
Bioorg Med Chem Lett; 2011 Aug; 21(15):4409-15. PubMed ID: 21733692
[TBL] [Abstract][Full Text] [Related]
20. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
